Keyphrases
Adenovirus
100%
Gene Therapy
100%
Prostate Cancer Cells
100%
Therapy Approaches
100%
Interleukin-12 (IL-12)
60%
RM-1
60%
Cell Death
40%
Prostate Cancer
40%
Cell Killing
40%
FasL
40%
Primary Tumor Tissue
20%
Apoptosis
20%
Median Survival
20%
LNCaP
20%
Primary Tumor
20%
Survival Benefit
20%
Human Cell Lines
20%
In Vivo Applications
20%
Incompetence
20%
PC-3 Cells
20%
Mouse Cell Line
20%
Pre-incubation
20%
In Vivo Exposure
20%
Fas Expression
20%
Ultra-low Dose
20%
Prostate Cells
20%
Co-inoculation
20%
Antifa
20%
Soluble Fas Ligand
20%
Medicine and Dentistry
Adenoviridae
100%
Cancer Cell
100%
Prostate Cancer
100%
Cell Line
100%
Gene Therapy
100%
Sensitization
100%
Primary Tumor
40%
Cell Death
40%
In Vitro
40%
Low Drug Dose
20%
Programmed Cell Death
20%
Fas Ligand
20%
Prostate Cell
20%
Fas Antibody
20%
Immunology and Microbiology
Adenoviridae
100%
Cancer Cell
100%
Cell Line
100%
Sensitization
100%
Cell Death
40%
In Vitro
40%
Human Cell
20%
Agonist
20%
Low Drug Dose
20%
Fas Ligand
20%
Fas Antibody
20%
Programmed Cell Death
20%
Replication
20%